FHD-286 as Monotherapy or Combination Therapy in Subjects With Advanced Hematologic Malignancies

Clinical trial NCT04891757 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04891757
Sponsor: Foghorn Therapeutics Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Hematologic Malignancy Relapsed Acute Myeloid Leukemia Refractory Acute Myeloid Leukemia Relapsed Myelodysplastic Syndromes Refractory Myelodysplastic Syndromes Relapsed Chronic Myelomonocytic Leukemia Refractory Chronic Myelomonocytic Leukemia

Start date: 2021-06-14
Primary completion: 2025-09-01
Enrollment: 144

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.